Juri Gelovani, M.D., Ph.D., chair of the Department of Biomedical Engineering for the Wayne State University School of Medicine, recently had two papers published in the Proceedings of National Academy of Sciences, a scientific journal that covers the topics of biological, physical and social sciences.

The first paper, "Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release," focuses on drug delivery to cancerous tumors in an attempt to create a non-invasive approach to treating breast cancer.

The second, "AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas," presents research on treating inoperable tumors through targeted gene therapy.

Dr. Gelovani is the leader of the molecular imaging program, a joint effort between the Barbara Ann Karmanos Cancer Institute and Wayne State University. His labs are expanding the research activities of the new Integrative Biosciences Center at WSU.

He has published more than 160 papers on cancer research, holds more than 15 patents, and is an editor for multiple publications. He has also received awards from the Alexander von Humboldt Foundation, the George and Barbara Bush Endowment for Innovative Cancer Research, and the Gold Medal for significant contributions to the field of molecular imaging from the Society for Molecular Imaging.